Abstract
There are several clinical scenarios that may not adhere to the precise definition of bacillus Calmette-Guérin (BCG)-unresponsive bladder cancer, but nevertheless indicate treatment unresponsiveness. We describe four such scenarios as a frame of reference in order to reach a consensus on the enrollment of such patients to current and future clinical trials in the BCG-unresponsive setting.
Original language | English (US) |
---|---|
Pages (from-to) | 437-439 |
Number of pages | 3 |
Journal | European urology |
Volume | 79 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2021 |
ASJC Scopus subject areas
- Urology